Jazz Pharmaceuticals (JAZZ) Amortization - Intangibles (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Amortization - Intangibles of $172.3 million for Q1 2026, up 11.59% year-over-year from $154.4 million in Q1 2025, and up 1.51% quarter-over-quarter from $169.7 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Amortization - Intangibles (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Amortization - Intangibles history runs 17 years deep, the most recent figure standing at $172.3 million for Q1 2026.
- In Q1 2026, Amortization - Intangibles rose 11.59% year-over-year to $172.3 million; the TTM figure through Mar 2026 stood at $672.5 million (up 7.43% YoY), while the FY2025 annual figure was $654.7 million, up 4.36% from the prior year.
- Amortization - Intangibles for Q1 2026 stood at $172.3 million, up from $169.7 million in the prior quarter.
- The five-year high for Amortization - Intangibles was $172.3 million in Q1 2026, with the low at $137.4 million in Q4 2022.
- The 5-year median for Amortization - Intangibles is $155.2 million (2024), against an average of $156.6 million.
- The sharpest annual moves came in 2022 and 2023: Amortization - Intangibles jumped 152.37% in 2022, then declined 12.96% in 2023.
- Jazz Pharmaceuticals' Amortization - Intangibles stood at $137.4 million in 2022, then increased by 10.31% to $151.6 million in 2023, then climbed by 4.85% to $158.9 million in 2024, then grew by 6.82% to $169.7 million in 2025, then gained by 1.51% to $172.3 million in 2026.
- Business Quant data shows JAZZ's Amortization - Intangibles at $172.3 million in Q1 2026, $169.7 million in Q4 2025, and $168.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 170.00 Mn |
| Mar 31, 2026 | 172.30 Mn |
| Dec 31, 2025 | 169.74 Mn |
| Sep 30, 2025 | 168.37 Mn |
| Jun 30, 2025 | 162.10 Mn |
| Mar 31, 2025 | 154.40 Mn |
| Dec 31, 2024 | 158.90 Mn |
| Sep 30, 2024 | 157.46 Mn |
| Jun 30, 2024 | 155.22 Mn |
| Mar 31, 2024 | 155.73 Mn |
| Dec 31, 2023 | 151.55 Mn |
| Sep 30, 2023 | 154.88 Mn |
| Jun 30, 2023 | 152.06 Mn |
| Mar 31, 2023 | 149.79 Mn |
| Dec 31, 2022 | 137.39 Mn |
| Sep 30, 2022 | 141.23 Mn |
| Jun 30, 2022 | 148.46 Mn |
| Mar 31, 2022 | 172.09 Mn |
| Dec 31, 2021 | 157.29 Mn |
| Sep 30, 2021 | 159.80 Mn |